CVSI - CV Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.3800
+0.2050 (+4.91%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close4.1750
Open4.1600
Bid0.00 x 0
Ask0.00 x 0
Day's Range4.0500 - 4.4300
52 Week Range0.3200 - 9.2000
Volume1,349,622
Avg. Volume1,319,140
Market Cap420.215M
Beta (3Y Monthly)1.48
PE Ratio (TTM)64.41
EPS (TTM)0.07
Earnings DateMar 27, 2019 - Apr 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • These 3 Stocks Trounced the Top Marijuana ETFs in 2018, and Here's Why They'll Do It Again This Year
    Motley Fool6 days ago

    These 3 Stocks Trounced the Top Marijuana ETFs in 2018, and Here's Why They'll Do It Again This Year

    Repeat performances could be in store for these big marijuana winners from last year.

  • GlobeNewswire11 days ago

    CV Sciences, Inc. Appoints New Chief Accounting Officer

    LAS VEGAS, Jan. 08, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp CBD products through its.

  • GlobeNewswire12 days ago

    CV Sciences, Inc. to Present at the 21st Annual ICR Conference

    LAS VEGAS, Jan. 07, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer of its industry-dominating brand of hemp CBD  products, PlusCBD Oil™, today.

  • GlobeNewswire16 days ago

    CV Sciences, Inc. Named One of the First U.S. Hemp Authority™ Certified Manufacturers

    LAS VEGAS, Jan. 03, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp CBD products through its.

  • ACCESSWIRE23 days ago

    CBD and Hemp Plays Positioned for a Big Year

    HENDERSON, NV / ACCESSWIRE / December 27, 2018 / After some selling at the end of the year, the cannabis sector looks prime for a major rally.Here are a few securities in the industry that look particularly ...

  • ACCESSWIRE24 days ago

    These 4 Marijuana Stocks Are Raising Eyebrows

    CORAL GABLES, FL/ ACCESSWIRE / December 26, 2018 / While all other sectors of the market are concerned with high volatility, the cannabis industry has enjoyed positive gains as a result of recent legislation passed that will allow producers to ramp up production to meet the needs of consumers in the space. Premier Health Group (PHGRF) (PHGI), MariMed Inc (MRMD), New Age Beverages Corp (NBEV), and CV Sciences, Inc (CVSI) are 4 pot stocks to pay attention to as we approach the new year. Premier Health Group (PHGRF) (PHGI) saw its company shares enjoy a 2.87% boost in midday trading on Wednesday afternoon, trading at $0.64 per share, up from $0.53 at the end of October and $0.59 on December 9.

  • ACCESSWIRElast month

    4 Pharma Stocks Getting a Boost on Thursday (12/20/18)

    CORAL GABLES, FL / ACCESSWIRE / December 20, 2018 / The healthcare industry is complicated, this much is certain, but amidst the complexities exist innovative approaches to healthcare that will ultimately provide the best quality of care for patients in the future. From advancements in the nascent telehealth industry to improved treatment options for patients, the healthcare sector may offer significant opportunities in the near future. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aevi Genomic Medicine, Inc (GNMX), Aurinia Pharmaceuticals, Inc (AUPH), and CV Sciences, Inc (CVSI) are 4 pharma stocks to pay attention to heading into the rest of the week.

  • Level Brands CEO: Farm Bill Will Prompt Big Retailers to Embrace CBD Products
    IPO Edgelast month

    Level Brands CEO: Farm Bill Will Prompt Big Retailers to Embrace CBD Products

    Martin Sumichrast, CEO of Level Brands, which Plans to Acquire cbdMD By John Jannarone With the passing of the Farm Bill Thursday, major U.S. retailers are likely to pounce on the opportunity to stock their shelves with CBD products after waiting years for such legal clarity. That’s according Level Brands CEO Martin Sumichrast, whose company […]

  • Level Brands CEO: Farm Bill Will Prompt Big Retailers to Embrace CBD Products
    IPO-Edge.comlast month

    Level Brands CEO: Farm Bill Will Prompt Big Retailers to Embrace CBD Products

    Martin Sumichrast, CEO of Level Brands, which Plans to Acquire cbdMD By John Jannarone With the passing of the Farm Bill Thursday, major U.S. retailers are likely to pounce on the opportunity to stock their shelves with CBD products after waiting years for such legal clarity. That’s according Level Brands CEO Martin Sumichrast, whose company […]

  • GlobeNewswirelast month

    CV Sciences, Inc. to Present at Biotech Showcase™ Investor Conference on January 7th in San Francisco

    The Company’s executive team to meet with investors at one of industry’s largest annual healthcare conferences LAS VEGAS, Dec. 20, 2018 --  CV Sciences, Inc. (OTCQB: CVSI).

  • ACCESSWIRElast month

    Farm Bill, Trump’s Comments, and Cuomo’s Move Make Cannabis Red Hot

    HENDERSON, NV / ACCESSWIRE / December 20, 2018 / December has been a big month for cannabis. First, the House and Senate passed the Farm Bill which will make hemp legal federally. Then, Trump commented ...

  • GlobeNewswirelast month

    CV Sciences, Inc. Featured as a Panelist at 2nd Annual Neuroscience Innovation Forum in San Francisco

    Forum to cover partnerships, industry keynotes and influential medical panels LAS VEGAS, Dec. 19, 2018 -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and.

  • Benzingalast month

    U.S. Hemp CBD Market to Triple by 2022

    The 2018 Farm Bill will restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years. With the removal of hemp from federal prohibition under the Controlled Substances Act of 1970 (CSA), the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate (CAGR) from 2018-2022. New Frontier Data’s Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market (or 3.3x) by 2022, representing a 27.2% 5-year CAGR.

  • Benzingalast month

    Farm Bill Effect: Impact on U.S. and Global Hemp Markets

    Pending President Trump’s signature next week, the 2018 Farm Bill is poised to restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years. With removal of hemp from federal prohibition under the Controlled Substances Act of 1970 (CSA), the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate (CAGR) from 2018-2022. Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market (3.3x) by 2022, representing a 27.2% 5-year CAGR.

  • ACCESSWIRElast month

    President Likely to End Marijuana Ban, These Stocks Could Benefit

    HENDERSON, NV / ACCESSWIRE / December 17, 2018 / Recently, he LA Times reported that President Trump declared he would "likely" support a congressional effort to end the federal ban on pot. The move would signify a significant change in the legal cannabis industry, as well as end the threat of a Justice Department crackdown. Today we are highlighting: CleanSpark, Inc. (CLSK), Aphria, Inc. (APHA), Aurora Cannabis, Inc. (ACB), CV Sciences, Inc. (CVSI), and Alliant Energy Corporation (LNT).

  • ACCESSWIRElast month

    Stocks Set to Breakout on the Heels of Farm Bill

    HENDERSON, NV / ACCESSWIRE /December 14, 2018 / The 2018 Farm Bill was passed by the Senate on Tuesday by a vote of 87-13. The next move is that the legislation heads to the House for a vote - and then ...

  • ACCESSWIRElast month

    This Unknown Stock With A Market Opportunity Rivaling Cannabis Could Offer Big Upside For Investors

    Medical marijuana and its derivatives are gaining rapid acceptance in the U.S. and Canada, and you can see the trend reflected in recent public market action from companies in this space, like Cara Therapeutics (CARA) and CV Sciences Inc. (CVSI) for example. Neurostimulation is also transforming numerous neurological conditions, just like medical marijuana.

  • ACCESSWIRElast month

    4 Marijuana Stocks To Watch As Farm Bill Passes House & Senate

    CORAL GABLES, FL / ACCESSWIRE / December 13, 2018 / The Senate passed the 2018 Farm Bill on December 11, 2018, and on December 12, 2018, the House followed suit. 4 pot stocks to watch during Farm Bill talks: Leafbuyer Technologies Inc. (LBUY), Marijuana Company of America (MCOA), CV Sciences (CVSI), and Hemp Inc. (HEMP).

  • TheStreet.comlast month

    Farm Bill Passes, and These Hemp Companies Will Be Big Winners

    The 2018 Farm Bill was passed by the Senate on Tuesday by a vote of 87-13. The next move is that the legislation heads to the House for a vote -- and then if it passes there, it goes to President Trump to be signed into law. The impact of this legislation on the cannabis industry is enormous.

  • ACCESSWIRElast month

    4 Marijuana Stocks to Watch a New Cannabis Legalization Initiatives Commence

    / The latest headlines out of New York have cannabis stocks jumping during premarket trading on Wednesday. The latest news from the Empire State highlights Governor Cuomo and plans for recreational legalization in New York. With this news circulating since late Tuesday, marijuana stocks have gotten much more attention.

  • ACCESSWIRElast month

    Pot Takes a Ton of Power

    HENDERSON, NV / ACCESSWIRE / December 11, 2018 / The $3.5 billion cannabis industry is one of the nation's most energy intensive, often demanding 24-hour indoor lighting rigs, heating, ventilation and ...

  • ACCESSWIRElast month

    Today's Research Reports on Trending Tickers: CV Sciences and Canopy Growth

    NEW YORK, NY / ACCESSWIRE / December 10, 2018 / U.S. stocks closed in the red on Friday as U.S. jobs report fell short of expectations and uncertainty over the U.S. -China trade talk spur markets lower. ...

  • ACCESSWIRElast month

    Green, Green, Green

    HENDERSON, NV / ACCESSWIRE / December 7, 2018 / The headline refers to cannabis, energy efficiency, and the profits that may be had by investors playing the two sectors. About 1% of all electricity consumption ...

  • GlobeNewswirelast month

    Breaking News: Expected Passage of 2018 Farm Bill on Monday Could Provide Opportunity to Gain Big in this Uncertain Market

    While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With the expected vote and passage of the 2018 Farm Bill on Monday, stocks that are in the CBD space are poised to benefit and should run counter to the current market downward trends. Stocks in the CBD and cannabis space have not been immune from the market’s downturn, but the expected passage of the bill should provide an opportunity to acquire high growth stocks in this bear market. The 2018 Farm Bill will nationally legalize the cultivation and farming of that plant.